To consolidate these findings, we assessed the efficacy of ABHD11 inhibition on synovial fluid mononuclear cells (SFMCs) isolated from the site of inflammation in a cohort of RA patients (Fig. 5f). Here, ABHD11 is linked to rheumatoid arthritis.